Search

Displaying results 4371 - 4380 of 10000 in total
  1. Drug

    BMS-863233

    go.drugbank.com/drugs/DB12357
    Investigational

    BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.

  2. Drug

    Oglemilast

    go.drugbank.com/drugs/DB12375
    Investigational

    Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

  3. Drug

    Lisofylline

    go.drugbank.com/drugs/DB12406
    Investigational

    Lisofylline has been investigated for the treatment of Type 1 Diabetes Mellitus.

  4. Drug

    Methyl pyrrolidone

    go.drugbank.com/drugs/DB12521
    Investigational

    N Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.

  5. Drug

    GSK-1292263

    go.drugbank.com/drugs/DB12627
    Investigational

    GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.

  6. Drug

    Ataciguat

    go.drugbank.com/drugs/DB12805
    Investigational

    Ataciguat has been investigated for the basic science of Aortic Valve Stenosis.

  7. Drug

    Zotarolimus

    go.drugbank.com/drugs/DB18761
    Investigational

    Zotarolimus is an immunosuppressant under investigation for use in drug-eluting stents.

  8. Drug

    Milveterol

    go.drugbank.com/drugs/DB05043
    Investigational

    GSK159797 ('797) is an inhaled, longer-acting Beta2 agonist developed for the treatment of respiratory disease such as asthma and COPD.

  9. Drug

    Dimethyl sulfone

    go.drugbank.com/drugs/DB14090
    Investigational

    Mixtures: Conart-MSM Sachet for Oral Solution, Condrosa-MSM Sachet for Oral Solution
  10. Drug

    Farletuzumab

    go.drugbank.com/drugs/DB05595
    Investigational

    Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.